News

July 23, 2019July 23, 2019

Sunstone Invests in Forendo’s Development of FOR-6219 for Endometriosis

News

Forendo Pharma has received €5 million (approximately $5.6 million) from Sunstone Life Science Ventures to develop its lead candidate FOR-6219 for the treatment of endometriosis. With this investment, Sunstone joins ... Read more

July 18, 2019July 18, 2019

Botulinum Toxin Can Quell Pelvic Muscle Spasms in Endometriosis, Study Says

News

Treating pelvic floor muscle spasms with botulinum toxin may reduce pain in people with endometriosis, a new study suggests. The study, “Botulinum toxin for chronic pelvic pain in women with ... Read more

July 15, 2019July 15, 2019

Middle-aged People with Endometriosis Seem at Lower Risk of Death, Finnish Study Suggests

News

A new study suggests that middle-aged people with surgically confirmed endometriosis have a slightly lower mortality rate than their peers who don’t have endometriosis. The reasons for this aren’t totally ... Read more

July 11, 2019July 11, 2019

DotLab Secures $10M to Fund Development of its Diagnostic Test for Endometriosis

News

DotLab has secured $10 million in Series A funding that will be used to drive the development of DotEndo, its proprietary noninvasive diagnostic test for endometriosis. “The revolutionary technology behind ... Read more

July 9, 2019July 9, 2019

Women With Endometriosis Use More Opioids, at Higher Doses, for Longer, U.S. Study Reports

News

Women with endometriosis fill prescriptions for opioids, with or without benzodiazepines, more commonly than those without this disorder, according to new research in the U.S. The findings also revealed higher ... Read more

July 3, 2019July 3, 2019

Mutations in Four Genes More Prevalent in Women with Endometriosis, Study Suggests

News

Women with endometriosis have an increased burden of mutations in four genes, called ZNF586, LUZP4, POP4 and UNC5CL, new data from Predictive Laboratories show. This is the first time these four ... Read more

June 27, 2019June 27, 2019

Insurance Status Affects Care Given and Sought by Patients in Puerto Rico, Study Finds

News

Health care disparities linked to public or private insurance reflect differences in socioeconomic status, and can affect the use of health care services and clinical outcomes in women with endometriosis, ... Read more

June 25, 2019June 25, 2019

VEGFR1 Blockade May be Viable Treatment for Women With Endometriosis, Mouse Study Shows

News

Blocking the activity of the vascular endothelial growth factor receptor 1 (VEGFR1) may be a viable treatment for women with endometriosis, a mouse study suggests. The study, “VEGF Receptor 1-Expressing ... Read more

June 20, 2019June 20, 2019

Orilissa Increases Workplace Productivity in People with Endometriosis, Study Suggests

News

Orilissa (elagolix), a treatment that reduces pain in endometriosis, can also have economic benefits, a study reports. The therapy allowed patients to work more and be more productive, which would ... Read more

June 18, 2019June 18, 2019

Debiopharm, Ipsen Extend Partnership for Patient Access to Decapeptyl

News

The pharmaceutical companies Debiopharm and Ipsen have extended their agreement for the development, manufacturing, and distribution of Decapeptyl (triptorelin), used in the treatment of endometriosis. This partnership, which began in ... Read more